In microarray gene expression experiments, several diverse conditions in each experiment (e.g., time, doses, replicates) increase the data points from tens of thousands of measurements for a single ...

Primary cutaneous lymphomas are a heterogeneous group of lymphomas of T- or B-cell origin that represent a relatively common type of lymphoma and their incidence appears to be increasing. The two ...

Although the superiority of expression-based biomarkers, as compared with traditional clinical staging, has been disputed, 33 a nationwide clinical trial is under way in the Netherlands in which ...

Pancreatic ductal adenocarcinoma (PDAC) is an important cause of malignancy-related death. In the United States, it ranks fifth among the leading causes of cancer death, accounting for approximately ...

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of ...

PHOENIX, August 16, 2004-5AM Solutions, a software solution provider enabling biomedical research, today announced the release of Microarray Enterprise Manager TM (MEM). The solution was delivered in ...

As a graduate student, Eric Olson learned something about DNA microarrays: Biochip data management can be vexing. His graduate adviser abandoned a number of microarray experiments because it was too ...

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...

This study aims to identify potential biomarkers of hepatocellular carcinoma (HCC) occurrence/recurrence and obesity, along with the molecular mechanisms that involve these biomarkers. Three ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...